NYSE:BXLT - Baxalta Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$46.02 0.00 (0.00 %)
(As of 06/21/2018 06:38 AM ET)
Previous Close$46.02
Today's Range$46.02 - $46.02
52-Week Range$29.83 - $46.52
VolumeN/A
Average Volume12.66 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield0.61%
BetaN/A
Baxalta logoBaxalta Incorporated (Baxalta) is a biopharmaceutical company with a portfolio of differentiated therapies that seek to address medical needs across various disease areas, including hemophilia, immunology and oncology. Baxalta's categories of products include Hemophilia products, such as Advate, Adynovate, Recombinate, Hemofil M, Immunate, Immunine, Rixubis and Prothromplex Total; Inhibitor Therapies products, including FEIBA and OBIZUR; Immunoglobulin Therapies products, which include GAMMAGARD LIQUID/KIOVIG, HYQVIA, GAMMAGARD S/D and SUBCUVIA; BioTherapeutics products, including FLEXBUMIN, BUMINATE, ARALAST NP, GLASSIA NP and CEPROTIN, and Oncology product, such as ONCASPAR. Baxalta Company develops, manufactures and markets a portfolio of treatments for hemophilia and other bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute medical conditions, as well as oncology treatments for acute lymphoblastic leukemia.

Receive BXLT News and Ratings via Email

Sign-up to receive the latest news and ratings for BXLT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNYSE:BXLT
CUSIPN/A
Phone+1-224-9402000

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins9.37%
Return on Equity14.28%
Return on Assets4.62%

Miscellaneous

EmployeesN/A
Outstanding Shares683,080,000

Baxalta (NYSE:BXLT) Frequently Asked Questions

What is Baxalta's stock symbol?

Baxalta trades on the New York Stock Exchange (NYSE) under the ticker symbol "BXLT."

How were Baxalta's earnings last quarter?

Baxalta Inc (NYSE:BXLT) announced its quarterly earnings results on Thursday, April, 28th. The biotechnology company reported $0.47 EPS for the quarter, beating analysts' consensus estimates of $0.46 by $0.01. The biotechnology company earned $1.50 billion during the quarter, compared to analyst estimates of $1.47 billion. Baxalta had a return on equity of 14.28% and a net margin of 9.37%. The firm's revenue was up 10.3% on a year-over-year basis. During the same period in the prior year, the company earned $0.40 earnings per share. View Baxalta's Earnings History.

Has Baxalta been receiving favorable news coverage?

Media stories about BXLT stock have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies positive and negative news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Baxalta earned a news impact score of 0.08 on Accern's scale. They also assigned headlines about the biotechnology company an impact score of 45.42 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

How do I buy shares of Baxalta?

Shares of BXLT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Baxalta's stock price today?

One share of BXLT stock can currently be purchased for approximately $46.02.

How can I contact Baxalta?

Baxalta's mailing address is 1200 Lakeside Dr, BANNOCKBURN, IL 60015-1243, United States. The biotechnology company can be reached via phone at +1-224-9402000.


MarketBeat Community Rating for Baxalta (BXLT)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  101 (Vote Outperform)
Underperform Votes:  93 (Vote Underperform)
Total Votes:  194
MarketBeat's community ratings are surveys of what our community members think about Baxalta and other stocks. Vote "Outperform" if you believe BXLT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BXLT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.